1-3 of 3
time-to-treatment
Close
Sort by
Journal Articles

Impact of treatment delay in acute myeloid leukemia revisited

Clinical Trials & Observations
Gunnar Juliusson, Oskar Hagberg, Vladimir Lj Lazarevic, Sören Lehmann, Martin Höglund
Journal: Blood Advances
Blood Adv (2021) 5 (3): 787–790.
https://doi.org/10.1182/bloodadvances.2020003806
Published: 2021
Includes: Supplemental data
Journal Articles

IgA levels at diagnosis predict for infections, time to treatment, and survival in chronic lymphocytic leukemia

Clinical Trials & Observations
Ganchimeg Ishdorj, Erin Streu, Pascal Lambert, Harbhajan S. Dhaliwal, Salaheddin M. Mahmud, Spencer B. Gibson, Versha Banerji, Aaron J. Marshall, James B. Johnston
Journal: Blood Advances
Blood Adv (2019) 3 (14): 2188–2198.
https://doi.org/10.1182/bloodadvances.2018026591
Published: 2019
Includes: Supplemental data
Journal Articles

Impact of genomic alterations on outcomes in myelofibrosis patients undergoing JAK1/2 inhibitor therapy

Clinical Trials & Observations
Jay Y. Spiegel, Caroline McNamara, James A. Kennedy, Tony Panzarella, Andrea Arruda, Tracy Stockley, Mahadeo Sukhai, Mariam Thomas, Justyna Bartoszko, Jenny Ho, Nancy Siddiq, Dawn Maze, Aaron Schimmer, Andre Schuh, Hassan Sibai, Karen Yee, Jamie Claudio, Rebecca Devlin, Mark D. Minden, Suzanne Kamel-Reid, Vikas Gupta
Journal: Blood Advances
Blood Adv (2017) 1 (20): 1729–1738.
https://doi.org/10.1182/bloodadvances.2017009530
Published: 2017
Includes: Supplemental data